Main Catalog

Found 70
Sort by
Nexus Conferences
Member Free
Non-Member $30.00

Rare Disease Therapies: Management Strategies to Pipeline Implications for Health Plans - Nexus 2017

Contact Hours: 1.5. The drug pipeline contains over 560 therapies in development for rare diseases.
Orphan Disease
Nexus Conferences
Member $15.00
Non-Member $30.00

Real-Time Pharmacy Benefits: Results and Learnings from a Real-World Implementation

Contact Hours: 1.5. Real-time pharmacy benefits (RTPB) deliver real-time access to medication pricing and restriction information at the point of prescribing.
Real-TIme Pharmacy
AMCP Annual Meeting
Member Free
Non-Member $30.00

Real-World Experience Managing Orphan Drugs Across Pharmacy and Medical Benefits

Contact Hours: 1.25. Recently approved drugs for orphan diseases have annual costs ranging from $90,000 to over $1 million, while also having variable value propositions.
Orphan Disease
Nexus Conferences
Member Free
Non-Member $30.00

Releasing Format Version 4.1: Updates, Perspectives and Application

Contact Hours: 1.5. The Academy of Managed Care Pharmacy developed the AMCP Format for Formulary Submission
Format 4.1
AMCP Annual Meeting
Member $39.00
Non-Member $79.00

Specialty Connect 2018 Bundle! - Annual Meeting 2018

A dynamic, cutting-edge look at evolving standards of care and emerging therapeutic options for hemophilia— designed for and with industry leaders, experts and Managed care pharmacists operating in the fast-growing specialty sector.
Hemophilia
AMCP Annual Meeting
Member $39.00
Non-Member $79.00

Specialty Connect 2019 Bundle! - Annual Meeting 2019

Gene therapy is a fascinating field that has the potential to improve the health of millions of patients. Promising advancements using gene therapy technology and techniques are offering hope for many with rare and serious diseases.
Gene Therapy
AMCP Annual Meeting
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development - Annual Meeting 2019

Contact Hours 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty
Nexus Conferences
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development - Nexus 2017

Contact Hours: 1.5. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty
Nexus Conferences
Member Free
Non-Member $30.00

Specialty Pharmaceuticals in Development - Nexus 2018

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs. It is anticipated that this trend will continue.
Specialty
Nexus Conferences
Member $15.00
Non-Member $30.00

Specialty Pharmaceuticals in Development - Nexus 2019

Contact Hours: 1.25. Over the last several years, approvals of specialty pharmaceuticals have far outpaced those of traditional drugs.
Specialty